Global 2-Way Foley Catheter Market Growth, Size, Trends Analysis - By Material, By Indication, By Usage, By End Use - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
Description
2-Way Foley Catheter Market Introduction and Overview
According to SPER Market Research, the Global 2-Way Foley Catheter Market is estimated to reach USD 488.34 million by 2034 with a CAGR of 5.71%.
The report includes an in-depth analysis of the Global 2-Way Foley Catheter Market, including market size and trends, product mix, Applications, and supplier analysis. The 2-way foley catheter market is expected to grow at a compound annual growth rate (CAGR) of 5.71% from 2025 to 2034, from an estimated USD 280.26 million in 2024. The increasing incidence of urological conditions like bladder cancer and incontinence, as well as the growing demand for minimally invasive procedures, are the main causes of this growth. Furthermore, it is projected that improvements in healthcare infrastructure, especially in developing nations, will support the market's growth.
By Material Insights
The global market is divided into two categories based on material: silicone foley catheters and latex foley catheters. Due to its distinctive qualities that improve patient comfort and lower the risk of infection, the silicone segment held the largest market share in 2024. In order to reduce the risk of catheter-related urinary tract infections (CAUTIs), these catheters are infused with silver ions, which inhibit microbial growth. Because of their smoothness and flexibility, silicone Foley catheters are non-allergic and perfect for people with sensitive skin. They also make insertion less painful. They are also more tissue-friendly and usually have larger lumens for better drainage, which makes them a popular option for long-term use and helps the segment expand.
By Indication Insights
The global market is classified into three categories based on indication: urinary incontinence, enlarged prostate gland/BPH and spinal cord injury. Over the course of the forecast period, the spinal cord injury (SCI) segment is anticipated to grow at the fastest CAGR. Because damage to the nerves that transmit signals from the bladder to the brain impairs the ability to empty the bladder, spinal cord injuries can interfere with the regulation of bladder function.
By Usage Insights
Based on usage, the global market is separated into two segments: short term use and long-term use. In 2024, the market was dominated by the short-term use segment. Catheterization for less than 30 days is generally considered short-term use; however, in order to reduce the risk of complications and infections, the European Association of Urology Nurses (EAUN) recommends a maximum duration of no more than 14 days. Over the course of the forecast period, this segment is expected to grow at the fastest rate. The growing number of hospitals stays and surgical procedures requiring temporary urine drainage is driving the short-term use segment. The need for short-duration catheterization solutions is also being driven by post-operative care protocols and an increase in acute urinary retention cases in healthcare settings.
By End Use Insights
Based on end use type, the global market is separated into two segments: hospitals and long-term care facilities. In 2024, the hospital segment had the biggest share. The need for more extensive surgical intervention has been primarily caused by an increase in the prevalence of urological diseases. Because of their extensive treatment options and ability to handle any emergencies that may arise during surgeries, hospitals are especially preferred for urological procedures and other related therapies. Hospitals draw more patients than other healthcare facilities because they are better suited to manage complicated cases and offer specialized care.
By Regional Insights
In 2024, the North American 2-way foley catheter market held the largest global revenue share, primarily due to specific medical scenarios like treating complex urological conditions like bladder fistulas or reconstructive surgeries, managing severe haematuria with continuous bladder irrigation, and managing postpartum haemorrhage using uterine tamponade. The region's sophisticated healthcare system, greater surgical rates, and emphasis on all-encompassing urological and maternal care support this demand.
Market Competitive Landscape
The 2-way Foley catheter market is fiercely competitive, with global med-device majors and agile regional manufacturers competing on antimicrobial/coatings and material innovation, regulatory approvals, pricing, and distribution partnerships, while buyers prioritize infection prevention, safety, and cost. Some of the key market players are AdvaCare Pharma, Advin Health Care, ANGIPLAST PRIVATE LIMITED, B. Braun SE, Bactiguard AB, Cardinal Health, Coloplast Corp., HEMC (Hospital Equipment Manufacturing Company), Medtronic, Sterimed Group.
Recent Developments:
In May 2024, Coloplast has launched the Luja catheter for women in four markets, including the United States and Europe. This expansion came after the successful introduction of a men's version in several global regions, which addressed specific needs for female patients with urinary incontinence. The launch aimed to improve women's comfort and discretion while managing these conditions.
In January 2023, Bactiguard received the first MDR (Medical Device Regulation 2017/745) approval in Europe for the latex BIP 2-way Foley Catheter. This approval followed a rigorous authorization process and represents a significant milestone for the company. The BIP 2-way Foley Catheter incorporates Bactiguard's patented infection prevention technology, which uses a thin noble metal alloy coating to reduce microbial adhesion, lowering the risk of healthcare-associated infections (HAIs) and catheter-associated urinary tract infections.
Scope of the report:
Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034
Segments covered By Material, By Indication, By Usage, By End Use
Regions covered North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa
Companies Covered
AdvaCare Pharma, Advin Health Care, ANGIPLAST PRIVATE LIMITED, B. Braun SE, Bactiguard AB, Cardinal Health, Coloplast Corp., HEMC (Hospital Equipment Manufacturing Company), Medtronic, Sterimed Group
Key Topics Covered in the Report
Global 2-Way Foley Catheter Market Size (FY'2021-FY'2034)
Overview of Global 2-Way Foley Catheter Market
Segmentation Global 2-Way Foley Catheter Market By Material (silicone foley catheters, latex foley catheters)
Segmentation Global 2-Way Foley Catheter Market By Indication (urinary incontinence, enlarged prostate gland/BPH, spinal cord injury)
Segmentation Global 2-Way Foley Catheter Market By Usage (short term use, long-term use)
Segmentation Global 2-Way Foley Catheter Market By End Use (hospitals, long-term care facilities)
Statistical Snap of Global 2-Way Foley Catheter Market
Expansion Analysis of Global 2-Way Foley Catheter Market
Problems and Obstacles in Global 2-Way Foley Catheter Market
Competitive Landscape in the Global 2-Way Foley Catheter Market
Details on Current Investment in Global 2-Way Foley Catheter Market
Competitive Analysis of Global 2-Way Foley Catheter Market
Prominent Players in the Global 2-Way Foley Catheter Market
SWOT Analysis of Global 2-Way Foley Catheter Market
Global 2-Way Foley Catheter Market Future Outlook and Projections (FY'2025-FY'2034)
Recommendations from Analyst
According to SPER Market Research, the Global 2-Way Foley Catheter Market is estimated to reach USD 488.34 million by 2034 with a CAGR of 5.71%.
The report includes an in-depth analysis of the Global 2-Way Foley Catheter Market, including market size and trends, product mix, Applications, and supplier analysis. The 2-way foley catheter market is expected to grow at a compound annual growth rate (CAGR) of 5.71% from 2025 to 2034, from an estimated USD 280.26 million in 2024. The increasing incidence of urological conditions like bladder cancer and incontinence, as well as the growing demand for minimally invasive procedures, are the main causes of this growth. Furthermore, it is projected that improvements in healthcare infrastructure, especially in developing nations, will support the market's growth.
By Material Insights
The global market is divided into two categories based on material: silicone foley catheters and latex foley catheters. Due to its distinctive qualities that improve patient comfort and lower the risk of infection, the silicone segment held the largest market share in 2024. In order to reduce the risk of catheter-related urinary tract infections (CAUTIs), these catheters are infused with silver ions, which inhibit microbial growth. Because of their smoothness and flexibility, silicone Foley catheters are non-allergic and perfect for people with sensitive skin. They also make insertion less painful. They are also more tissue-friendly and usually have larger lumens for better drainage, which makes them a popular option for long-term use and helps the segment expand.
By Indication Insights
The global market is classified into three categories based on indication: urinary incontinence, enlarged prostate gland/BPH and spinal cord injury. Over the course of the forecast period, the spinal cord injury (SCI) segment is anticipated to grow at the fastest CAGR. Because damage to the nerves that transmit signals from the bladder to the brain impairs the ability to empty the bladder, spinal cord injuries can interfere with the regulation of bladder function.
By Usage Insights
Based on usage, the global market is separated into two segments: short term use and long-term use. In 2024, the market was dominated by the short-term use segment. Catheterization for less than 30 days is generally considered short-term use; however, in order to reduce the risk of complications and infections, the European Association of Urology Nurses (EAUN) recommends a maximum duration of no more than 14 days. Over the course of the forecast period, this segment is expected to grow at the fastest rate. The growing number of hospitals stays and surgical procedures requiring temporary urine drainage is driving the short-term use segment. The need for short-duration catheterization solutions is also being driven by post-operative care protocols and an increase in acute urinary retention cases in healthcare settings.
By End Use Insights
Based on end use type, the global market is separated into two segments: hospitals and long-term care facilities. In 2024, the hospital segment had the biggest share. The need for more extensive surgical intervention has been primarily caused by an increase in the prevalence of urological diseases. Because of their extensive treatment options and ability to handle any emergencies that may arise during surgeries, hospitals are especially preferred for urological procedures and other related therapies. Hospitals draw more patients than other healthcare facilities because they are better suited to manage complicated cases and offer specialized care.
By Regional Insights
In 2024, the North American 2-way foley catheter market held the largest global revenue share, primarily due to specific medical scenarios like treating complex urological conditions like bladder fistulas or reconstructive surgeries, managing severe haematuria with continuous bladder irrigation, and managing postpartum haemorrhage using uterine tamponade. The region's sophisticated healthcare system, greater surgical rates, and emphasis on all-encompassing urological and maternal care support this demand.
Market Competitive Landscape
The 2-way Foley catheter market is fiercely competitive, with global med-device majors and agile regional manufacturers competing on antimicrobial/coatings and material innovation, regulatory approvals, pricing, and distribution partnerships, while buyers prioritize infection prevention, safety, and cost. Some of the key market players are AdvaCare Pharma, Advin Health Care, ANGIPLAST PRIVATE LIMITED, B. Braun SE, Bactiguard AB, Cardinal Health, Coloplast Corp., HEMC (Hospital Equipment Manufacturing Company), Medtronic, Sterimed Group.
Recent Developments:
In May 2024, Coloplast has launched the Luja catheter for women in four markets, including the United States and Europe. This expansion came after the successful introduction of a men's version in several global regions, which addressed specific needs for female patients with urinary incontinence. The launch aimed to improve women's comfort and discretion while managing these conditions.
In January 2023, Bactiguard received the first MDR (Medical Device Regulation 2017/745) approval in Europe for the latex BIP 2-way Foley Catheter. This approval followed a rigorous authorization process and represents a significant milestone for the company. The BIP 2-way Foley Catheter incorporates Bactiguard's patented infection prevention technology, which uses a thin noble metal alloy coating to reduce microbial adhesion, lowering the risk of healthcare-associated infections (HAIs) and catheter-associated urinary tract infections.
Scope of the report:
Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034
Segments covered By Material, By Indication, By Usage, By End Use
Regions covered North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa
Companies Covered
AdvaCare Pharma, Advin Health Care, ANGIPLAST PRIVATE LIMITED, B. Braun SE, Bactiguard AB, Cardinal Health, Coloplast Corp., HEMC (Hospital Equipment Manufacturing Company), Medtronic, Sterimed Group
Key Topics Covered in the Report
Global 2-Way Foley Catheter Market Size (FY'2021-FY'2034)
Overview of Global 2-Way Foley Catheter Market
Segmentation Global 2-Way Foley Catheter Market By Material (silicone foley catheters, latex foley catheters)
Segmentation Global 2-Way Foley Catheter Market By Indication (urinary incontinence, enlarged prostate gland/BPH, spinal cord injury)
Segmentation Global 2-Way Foley Catheter Market By Usage (short term use, long-term use)
Segmentation Global 2-Way Foley Catheter Market By End Use (hospitals, long-term care facilities)
Statistical Snap of Global 2-Way Foley Catheter Market
Expansion Analysis of Global 2-Way Foley Catheter Market
Problems and Obstacles in Global 2-Way Foley Catheter Market
Competitive Landscape in the Global 2-Way Foley Catheter Market
Details on Current Investment in Global 2-Way Foley Catheter Market
Competitive Analysis of Global 2-Way Foley Catheter Market
Prominent Players in the Global 2-Way Foley Catheter Market
SWOT Analysis of Global 2-Way Foley Catheter Market
Global 2-Way Foley Catheter Market Future Outlook and Projections (FY'2025-FY'2034)
Recommendations from Analyst
Table of Contents
273 Pages
- 1. Introduction
- 1.1. Scope of the report
- 1.2. Market segment analysis
- 2. Research Methodology
- 2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPERs internal database
- 2.1.4. Premium insight from KOLs
- 2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
- 2.3. Data triangulation
- 3. Executive Summary
- 4. Market Dynamics
- 4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
- 5. Market variable and outlook
- 5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
- 5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
- 5.3. PORTERs Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
- 5.4. Heat Map Analysis
- 6. Competitive Landscape
- 6.1. Global 2-Way Foley Catheter Market Manufacturing Base Distribution, Sales Area, Product Type
- 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global 2-Way Foley Catheter Market
- 7. Global 2-Way Foley Catheter Market, By Material 2021-2034 (USD Million)
- 7.1. Silicone Foley Catheters
- 7.2. Latex Foley Catheters
- 8. Global 2-Way Foley Catheter Market, By Indication 2021-2034 (USD Million)
- 8.1. Urinary Incontinence
- 8.2. Enlarged Prostate Gland/ BPH
- 8.3. Spinal Cord Injury
- 8.4. Others
- 9. Global 2-Way Foley Catheter Market, By Usage 2021-2034 (USD Million)
- 9.1. Short-Term Use
- 9.2. Long-Term Use
- 10. Global 2-Way Foley Catheter Market, By End-Use 2021-2034 (USD Million)
- 10.1. Hospitals
- 10.2. Long Term Care Facilities
- 10.3. Others
- 11. Global 2-Way Foley Catheter Market 2021-2034 (USD Million)
- 11.1. Global 2-Way Foley Catheter Market Size and Market Share
- 12. Global 2-Way Foley Catheter Market, By Region, 2021-2034 (USD Million)
- 12.1. Asia-Pacific
- 12.1.1. Australia
- 12.1.2. China
- 12.1.3. India
- 12.1.4. Japan
- 12.1.5. South Korea
- 12.1.6. Rest of Asia-Pacific
- 12.2. Europe
- 12.2.1. France
- 12.2.2. Germany
- 12.2.3. Italy
- 12.2.4. Spain
- 12.2.5. United Kingdom
- 12.2.6. Rest of Europe
- 12.3. Middle East and Africa
- 12.3.1. Kingdom of Saudi Arabia
- 12.3.2. United Arab Emirates
- 12.3.3. Qatar
- 12.3.4. South Africa
- 12.3.5. Egypt
- 12.3.6. Morocco
- 12.3.7. Nigeria
- 12.3.8. Rest of Middle-East and Africa
- 12.4. North America
- 12.4.1. Canada
- 12.4.2. Mexico
- 12.4.3. United States
- 12.5. Latin America
- 12.5.1. Argentina
- 12.5.2. Brazil
- 12.5.3. Rest of Latin America
- 13. Company Profile
- 13.1. AdvaCare Pharma
- 13.1.1. Company details
- 13.1.2. Financial outlook
- 13.1.3. Product summary
- 13.1.4. Recent developments
- 13.2. Advin Health Care
- 13.2.1. Company details
- 13.2.2. Financial outlook
- 13.2.3. Product summary
- 13.2.4. Recent developments
- 13.3. Angiplast Private Limited
- 13.3.1. Company details
- 13.3.2. Financial outlook
- 13.3.3. Product summary
- 13.3.4. Recent developments
- 13.4. B. Braun SE
- 13.4.1. Company details
- 13.4.2. Financial outlook
- 13.4.3. Product summary
- 13.4.4. Recent developments
- 13.5. Bactiguard AB
- 13.5.1. Company details
- 13.5.2. Financial outlook
- 13.5.3. Product summary
- 13.5.4. Recent developments
- 13.6. Cardinal Health
- 13.6.1. Company details
- 13.6.2. Financial outlook
- 13.6.3. Product summary
- 13.6.4. Recent developments
- 13.7. Coloplast Corp.
- 13.7.1. Company details
- 13.7.2. Financial outlook
- 13.7.3. Product summary
- 13.7.4. Recent developments
- 13.8. HEMC (Hospital Equipment Manufacturing Company)
- 13.8.1. Company details
- 13.8.2. Financial outlook
- 13.8.3. Product summary
- 13.8.4. Recent developments
- 13.9. Medtronic
- 13.9.1. Company details
- 13.9.2. Financial outlook
- 13.9.3. Product summary
- 13.9.4. Recent developments
- 13.10. Sterimed Group
- 13.10.1. Company details
- 13.10.2. Financial outlook
- 13.10.3. Product summary
- 13.10.4. Recent developments
- 13.11. Others
- 14. Conclusion
- 15. List of Abbreviations
- 16. Reference Links
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
